Ramsay Santé revenue climbs despite inflationary pressures

Ramsay Santé, a European integrated care provider and part of the Ramsay Health Care Group (ASX:RHC), logged financial fundamentals in its latest nine-month earnings report.

The group reported a 3.1% increase in revenue to €4 billion, bolstered by strong performance in the Nordics and a steady demand for high-quality medical services in France.

The growth was further supported by positive price indexation and the strategic integration of the St Göran contract.

Operational profitability showed marked improvement, with 9M EBITDA rising 4.4% to €460 million, representing an 11.6% margin.

These gains were driven by rigorous efficiency programmes and enhanced productivity, which offset a €20 million shortfall in French revenue guarantees and the disruptive impact of medical practitioner strikes in early 2026.

The third quarter saw a 12.3% rise in EBITDA, reflecting disciplined cost control across all geographies.

The company’s financial health continues to stabilise, with net losses narrowing to €28 million—a €26 million year-on-year improvement—following debt refinancing and lowered financing costs.

Net leverage also improved to 5.1x, down from 5.7x in March 2025.

While the group continues to struggle with insufficient public funding to match rising inflation, the success of the "Yes We Care" programme has provided a platform for its upcoming strategic plan.